Pentoxifylline inhibits liver fibrosis via hedgehog signaling pathway

  • Hui Li (李 慧)
  • Juan Hua (华 娟)
  • Chun-xia Guo (郭春霞)
  • Wei-xian Wang (王伟仙)
  • Bao-ju Wang (王宝菊)
  • Dong-liang Yang (杨东亮)
  • Ping Wei (魏 屏)Email author
  • Yin-ping Lu (卢银平)Email author


Infection of schistosomiasis japonica may eventually lead to liver fibrosis, and no effective antifibrotic therapies are available but liver transplantation. Hedgehog (HH) signaling pathway has been involved in the process and is a promising target for treating liver fibrosis. This study aimed to explore the effects of pentoxifylline (PTX) on liver fibrosis induced by schistosoma japonicum infection by inhibiting the HH signaling pathway. Phorbol12-myristate13-acetate (PMA) was used to induce human acute mononuclear leukemia cells THP-1 to differentiate into macrophages. The THP-1-derived macrophages were stimulated by soluble egg antigen (SEA), and the culture supernatants were collected for detection of activation of macrophages. Cell Counting Kit-8 (CCK-8) was used to detect the cytotoxicity of the culture supernatant and PTX on the LX-2 cells. The LX-2 cells were administered with activated culture supernatant from macrophages and(or) PTX to detect the transforming growth factor-β gene expression. The mRNA expression of shh and gli-1, key parts in HH signaling pathway, was detected. The mRNA expression of shh and gli-1 was increased in LX-2 cells treated with activated macrophages-derived culture supernatant, suggesting HH signaling pathway may play a key role in the activation process of hepatic stellate cells (HSCs). The expression of these genes decreased in LX-2 cells co-cultured with both activated macrophages-derived culture supernatant and PTX, indicating PTX could suppress the activation process of HSCs. In conclusion, these data provide evidence that PTX prevents liver fibrogenesis in vitro by the suppression of HH signaling pathway.

Key words

pentoxifylline schistosomiasis japonica hedgehog signaling pathway macrophages hepatic stellate cells 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Iredale JP. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest, 2007, 117(3): 539–548CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Qu Z, Lou D, Pan Y. The role of IkappaBalpha in TNF-alpha-induced apoptosis in hepatic stellate cell line HSC-T6. J Huazhong Univ Sci Technol Med Sci, 2007, 27(4): 407–410CrossRefPubMedGoogle Scholar
  3. 3.
    Omenetti A, Choi S, Michelotti G, et al. Hedgehog signaling in the liver. J Hepatol, 2011, 54(2): 366–373CrossRefPubMedGoogle Scholar
  4. 4.
    Toda K, Kumagai N, Kaneko F, et al. Pentoxifylline prevents pig serum-induced rat liver fibrosis by inhibiting interleukin-6 production. J Gastroenterol Hepatol, 2009, 24(5): 860–865CrossRefPubMedGoogle Scholar
  5. 5.
    Lebrec D, Thabut D, Oberti F, et al. Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis. Gastroenterology, 2010, 138(5): 1755–1762CrossRefPubMedGoogle Scholar
  6. 6.
    Qin Z. The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis, 2012, 221(1): 2–11CrossRefPubMedGoogle Scholar
  7. 7.
    Lai S, Chen T. Experimental study on killing fluorescent M. bovis BCG by IFN-γ activated THP-1 derived macrophages. Chin J Anituberc (Chinese), 2014, 36(5): 362–368Google Scholar
  8. 8.
    Daigneault M, Preston JA, Marriott HM, et al. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One, 2010, 5(1): e8668CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Huang Y, Liu J, Xu Y, et al. Reduction of insulin resistance in HepG2 cells by knockdown of LITAF expression in human THP-1 macrophages. J Huazhong Univ Sci Technol Med Sci, 2012, 32(1): 53–58CrossRefPubMedGoogle Scholar
  10. 10.
    Luedde T, Schwabe RF. NF-kappa B in the liver—linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol, 2011, 8(2): 108–118CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Xu H, Zhu W. Inhibition of culture supernatant of mesenchymal stem cells on macrophages RAW264. 7 activated by soluble egg antigen of schistosoma japonicum. Chin J Parasitol Parasit Dis (Chinese), 2011, 29(6): 425–430Google Scholar
  12. 12.
    Zhang W, Wang H, Tong Q, et al. Involvement of TLR2-MyD88 in abnormal expression of miR-146a in peripheral blood monocytes of patients with chronic hepatitis C. J Huazhong Univ Sci Technol Med Sci, 2015, 35(2): 219–224CrossRefPubMedGoogle Scholar
  13. 13.
    Ueberham E, Low R, Ueberham U, et al. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology, 2003, 37(5): 1067–1078CrossRefPubMedGoogle Scholar
  14. 14.
    Yang JJ, Tao H, Li J. Hedgehog signaling pathway as key player in liver fibrosis: newinsights and perspectives. Expert Opin Ther Targets, 2014, 18(9): 1011–1021CrossRefPubMedGoogle Scholar
  15. 15.
    Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med, 1994, 331(19): 1286–1292CrossRefPubMedGoogle Scholar
  16. 16.
    Shi YF, Fong CC, Zhang Q, et al. Hypoxia induces the activation of human hepatic stellate cells LX-2 through TGF-beta signaling pathway. FEBS Letters, 2007, 581(2): 203–210CrossRefPubMedGoogle Scholar
  17. 17.
    Yao Y, Zou R, Liu X, et al. Telmisartan but not valsartan inhibits TGF-beta-mediated accumulation of extracellular matrix via activation of PPARgamma. J Huazhong Univ Sci Technol Med Sci, 2008, 28(5): 543–548CrossRefPubMedGoogle Scholar
  18. 18.
    Tang J, Zhan C, Zhou J. Effects of tanshinone IIA on transforming growth factor beta1-Smads signal pathway in renal interstitial fibroblasts of rats. J Huazhong Univ Sci Technol Med Sci, 2008, 28(5): 539–542CrossRefPubMedGoogle Scholar
  19. 19.
    Ren ZP, Sun LP, Xia YC, et al. Effect of the protease inhibitor MG132 on the transforming growth factor-beta/Smad signaling pathway in HSC-T6 cells. J Huazhong Univ Sci Technol Med Sci, 2013, 33(4): 501–504CrossRefPubMedGoogle Scholar
  20. 20.
    Xu C, Hao Y, Lu Y, et al. Upregulation of Toll-like receptor 4 on T cells in PBMCs is associated with the disease aggravation of HBV-related acute-on-chronic liver failure. J Huazhong Univ Sci Technol Med Sci, 2015, 35(6): 910–915CrossRefPubMedGoogle Scholar
  21. 21.
    Sicklick JK, Li YX, Choi SS, et al. Role for hedgehog signaling in hepatic stellate cell activation and viability. Lab Invest, 2005, 85(11): 1368–1380CrossRefPubMedGoogle Scholar
  22. 22.
    Choi SS, Omenetti A, Witek RP, et al. Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. Am J Physiol Gastrointest Liver Physiol, 2009, 297(6): G1093–1106CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Chen Y, Choi SS, Michelotti GA, et al. Hedgehog controls hepatic stellate cell fate by regulating metabolism. Gastroenterology, 2012, 143(5): 1319–1329. e1-11CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Choi SS, Witek RP, Yang L, et al. Activation of Rac1 promotes hedgehog-mediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cells. Hepatology, 2010, 52(1): 278–290CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Yang L, Wang Y, Mao H, et al. Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells. J Hepatol, 2008, 48(1): 98–106CrossRefPubMedGoogle Scholar
  26. 26.
    Syn W-K, Choi SS, Liaskou E, et al. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology, 2011, 53(1): 106–115CrossRefPubMedGoogle Scholar
  27. 27.
    Mederacke I, Hsu CC, Troeger JS, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun, 2013, 4(7): 657–678Google Scholar
  28. 28.
    Seki E, Schwabe RF. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology, 2015, 61(3): 1066–1079CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Friedman SL. Evolving challenges in heptic fibrosis. Nat Rev Gastroenterol Hepatol, 2010, 7(8): 425–436CrossRefPubMedGoogle Scholar
  30. 30.
    Xiong LJ, Zhu JF, Luo DD, et al. Effects of pentoxifylline on the hepatic content of TGF-beta1 and collagen 1 Schistosomiasis japonica mice with liver fibrosis. World J Gastroenterol, 2003, 9(1): 152–154CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    El-Lakkany N, El-Din SS, Ebeid F. The use of pentoxifylline as adjuvant therapy with praziquantel downregulates profibrogenic cytokines, collagen deposition and oxidative stress in experimental schistosomiasis mansoni. Exp Parasitol, 2011, 129(2): 152–157CrossRefPubMedGoogle Scholar

Copyright information

© Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Hui Li (李 慧)
    • 1
  • Juan Hua (华 娟)
    • 1
  • Chun-xia Guo (郭春霞)
    • 1
  • Wei-xian Wang (王伟仙)
    • 1
  • Bao-ju Wang (王宝菊)
    • 1
  • Dong-liang Yang (杨东亮)
    • 1
  • Ping Wei (魏 屏)
    • 1
    Email author
  • Yin-ping Lu (卢银平)
    • 1
    Email author
  1. 1.Institute of Infection and Immunology, Department of Infectious Diseases, Union Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina

Personalised recommendations